Trademarkia Logo

Australia

AU$
Trademark Search
EVAMPLIX (BALSTILIMAB)

View On IPO.GOV.AU

EVAMPLIX (BALSTILIMAB)
Cancelled: Cancelled at the request of IB

Last updated on 21 Feb 2024

Owner Info

Agenus Inc.

3 Forbes Road

Lexington MA 02421, UNITED STATES OF AMERICA

Serial Number

2253300 filed on 19 Jan 2022

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

EVAMPLIX (BALSTILIMAB)

Classification Information

Class [005]
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections Read More

Mark Details

Serial Number

2253300

Registered On

NA

Renewal On

NA

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

19 Jul 2021

Mark Type

US

Legal History

Show more

Status DateAction Taken
21st Feb 2024Status change to Voided
17th Jun 2023International Registration in Australia Refused correspondence sent
16th Jun 2023Status change to Lapsed/Not Protected
4th Mar 2023IRDA - Opposition Still Possible Notice correspondence sent
9th Mar 2022Adverse Report (Examination) correspondence sent
8th Mar 2022IP Right has been Examined
4th Mar 2022Awaiting examination
4th Mar 2022Examination expedited
4th Mar 2022Word and image indexing completed
3rd Mar 2022IP Right Filed Published